These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3097071)

  • 1. The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4.
    Sedgwick JD; Mason DW
    J Neuroimmunol; 1986 Dec; 13(2):217-32. PubMed ID: 3097071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of anti-CD4 monoclonal antibody prolongs survival in longtailed macaques with experimental allergic encephalomyelitis.
    Rose LM; Alvord EC; Hruby S; Jackevicius S; Petersen R; Warner N; Clark EA
    Clin Immunol Immunopathol; 1987 Dec; 45(3):405-23. PubMed ID: 2445510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of experimental allergic encephalomyelitis in Lewis rats by monoclonal anti-T cell antibodies.
    Brinkman CJ; Ter Laak HJ; Hommes OR
    J Neuroimmunol; 1985 Jan; 7(4):231-8. PubMed ID: 3155525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of clinical experimental allergic encephalomyelitis in the rat with monoclonal antibodies.
    Brostoff SW; White TM
    J Neuroimmunol; 1986 Dec; 13(2):233-40. PubMed ID: 3097072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblasts.
    Schluesener HJ
    J Neuroimmunol; 1987 Apr; 14(3):339-43. PubMed ID: 3104402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
    Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
    J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD45RC and Ia antigen in the spinal cord in acute experimental allergic encephalomyelitis: an immunocytochemical and flow cytometric study.
    McCombe PA; Fordyce BW; de Jersey J; Yoong G; Pender MP
    J Neurol Sci; 1992 Dec; 113(2):177-86. PubMed ID: 1336796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against I-A and I-E determinants inhibit the activation and function of encephalitogenic T-lymphocyte lines.
    Offner H; Brostoff SW; Vandenbark AA
    Cell Immunol; 1986 Jul; 100(2):364-73. PubMed ID: 2428509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
    Mannie MD; Morrison-Plummer J; McConnell TJ
    J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
    Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE.
    Matsumoto Y; Fujiwara M
    J Neurol Sci; 1987 Jan; 77(1):35-47. PubMed ID: 2433404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat.
    Williams KC; Zhao RW; Ueno K; Hickey WF
    J Neurosci Res; 1996 Sep; 45(6):747-57. PubMed ID: 8892086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4.
    Tran GT; Carter N; He XY; Spicer TS; Plain KM; Nicolls M; Hall BM; Hodgkinson SJ
    Int Immunol; 2001 Sep; 13(9):1109-20. PubMed ID: 11526091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by CTLA4Ig of experimental allergic encephalomyelitis.
    Arima T; Rehman A; Hickey WF; Flye MW
    J Immunol; 1996 Jun; 156(12):4916-24. PubMed ID: 8648142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.